Literature DB >> 14744150

Characterization of the adenosinetriphosphatase and transport activities of purified cystic fibrosis transmembrane conductance regulator.

Christian J Ketchum1, Garnepudi V Rajendrakumar, Peter C Maloney.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) functions in vivo as a cAMP-activated chloride channel. A member of the ATP-binding cassette superfamily of membrane transporters, CFTR contains two transmembrane domains (TMDs), two nucleotide-binding domains (NBDs), and a regulatory (R) domain. It is presumed that CFTR couples ATP hydrolysis to channel gating, and as a first step in addressing this issue directly, we have established conditions for purification of biochemical quantities of human CFTR expressed in Sf9 insect cells. Use of an 8-azido[alpha-(32)P]ATP-binding and vanadate-trapping assay allowed us to devise conditions to preserve CFTR function during purification of a C-terminal His(10)-tagged variant after solubilization with lysophosphatidylglycerol (1%) and diheptanoylphosphatidylcholine (0.3%) in the presence of excess phospholipid. Study of purified and reconstituted CFTR showed that it binds nucleotide with an efficiency comparable to that of P-glycoprotein and that it hydrolyzes ATP at rates sufficient to account for presumed in vivo activity [V(max) of 58 +/- 5 nmol min(-1) (mg of protein)(-1), K(M)(MgATP) of 0.15 mM]. In further work, we found that neither nucleotide binding nor ATPase activity was altered by phosphorylation (using protein kinase A) or dephosphorylation (with protein phosphatase 2B); we also observed inhibition (approximately 40%) of ATP hydrolysis by reduced glutathione but not by DTT. To evaluate CFTR function as an anion channel, we introduced an in vitro macroscopic assay based on the equilibrium exchange of proteoliposome-entrapped radioactive tracers. This revealed a CFTR-dependent transport of (125)I that could be inhibited by known chloride channel blockers; no significant CFTR-dependent transport of [alpha-(32)P]ATP was observed. We conclude that heterologous expression of CFTR in Sf9 cells can support manufacture and purification of fully functional CFTR. This should aid in further biochemical characterization of this important molecule.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744150      PMCID: PMC2587309          DOI: 10.1021/bi035382a

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  54 in total

1.  Identification of cystic fibrosis transmembrane conductance regulator in renal endosomes.

Authors:  I T Crawford; P C Maloney
Journal:  Methods Enzymol       Date:  1998       Impact factor: 1.600

2.  A novel procedure for the efficient purification of the cystic fibrosis transmembrane conductance regulator (CFTR).

Authors:  M Ramjeesingh; C Li; E Garami; L J Huan; M Hewryk; Y Wang; K Galley; C E Bear
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

Review 3.  ATP hydrolysis cycles and mechanism in P-glycoprotein and CFTR.

Authors:  A E Senior; D C Gadsby
Journal:  Semin Cancer Biol       Date:  1997-06       Impact factor: 15.707

4.  Evaluation of secondary structure of OxlT, the oxalate transporter of Oxalobacter formigenes, by circular dichroism spectroscopy.

Authors:  D Fu; P C Maloney
Journal:  J Biol Chem       Date:  1997-01-24       Impact factor: 5.157

5.  Lysophosphatidylglycerol: a novel effective detergent for solubilizing and purifying the cystic fibrosis transmembrane conductance regulator.

Authors:  P Huang; Q Liu; G A Scarborough
Journal:  Anal Biochem       Date:  1998-05-15       Impact factor: 3.365

6.  Regulation of CFTR by protein phosphatase 2B and protein kinase C.

Authors:  H Fischer; B Illek; T E Machen
Journal:  Pflugers Arch       Date:  1998-07       Impact factor: 3.657

7.  Purification of functional human P-glycoprotein expressed in Saccharomyces cerevisiae.

Authors:  Q Mao; G A Scarborough
Journal:  Biochim Biophys Acta       Date:  1997-07-05

8.  ATPase activity of the cystic fibrosis transmembrane conductance regulator.

Authors:  C Li; M Ramjeesingh; W Wang; E Garami; M Hewryk; D Lee; J M Rommens; K Galley; C E Bear
Journal:  J Biol Chem       Date:  1996-11-08       Impact factor: 5.157

9.  Mutations in either nucleotide-binding site of P-glycoprotein (Mdr3) prevent vanadate trapping of nucleotide at both sites.

Authors:  I L Urbatsch; L Beaudet; I Carrier; P Gros
Journal:  Biochemistry       Date:  1998-03-31       Impact factor: 3.162

10.  Glutathione permeability of CFTR.

Authors:  P Linsdell; J W Hanrahan
Journal:  Am J Physiol       Date:  1998-07
View more
  8 in total

1.  Membrane protein stability can be compromised by detergent interactions with the extramembranous soluble domains.

Authors:  Zhengrong Yang; Chi Wang; Qingxian Zhou; Jianli An; Ellen Hildebrandt; Luba A Aleksandrov; John C Kappes; Lawrence J DeLucas; John R Riordan; Ina L Urbatsch; John F Hunt; Christie G Brouillette
Journal:  Protein Sci       Date:  2014-05-03       Impact factor: 6.725

2.  A survey of detergents for the purification of stable, active human cystic fibrosis transmembrane conductance regulator (CFTR).

Authors:  Ellen Hildebrandt; Qinghai Zhang; Natasha Cant; Haitao Ding; Qun Dai; Lingling Peng; Yu Fu; Lawrence J DeLucas; Robert Ford; John C Kappes; Ina L Urbatsch
Journal:  Biochim Biophys Acta       Date:  2014-07-24

3.  Modulation of the hepatocyte rough endoplasmic reticulum single chloride channel by nucleotide-Mg2+ interaction.

Authors:  M Ashrafpour; J Fahanik Babaei; R Saghiri; H Sepehri; H Sharifi
Journal:  Pflugers Arch       Date:  2012-06-10       Impact factor: 3.657

4.  Specific stabilization of CFTR by phosphatidylserine.

Authors:  Ellen Hildebrandt; Netaly Khazanov; John C Kappes; Qun Dai; Hanoch Senderowitz; Ina L Urbatsch
Journal:  Biochim Biophys Acta Biomembr       Date:  2016-11-30       Impact factor: 3.747

5.  The Slc26a4 transporter functions as an electroneutral Cl-/I-/HCO3- exchanger: role of Slc26a4 and Slc26a6 in I- and HCO3- secretion and in regulation of CFTR in the parotid duct.

Authors:  Nikolay Shcheynikov; Dongki Yang; Youxue Wang; Weizong Zeng; Lawrence P Karniski; Insuk So; Susan M Wall; Shmuel Muallem
Journal:  J Physiol       Date:  2008-06-19       Impact factor: 5.182

6.  Substitution of Yor1p NBD1 residues improves the thermal stability of Human Cystic Fibrosis Transmembrane Conductance Regulator.

Authors:  B M Xavier; E Hildebrandt; F Jiang; H Ding; J C Kappes; I L Urbatsch
Journal:  Protein Eng Des Sel       Date:  2017-10-01       Impact factor: 1.650

7.  How Phosphorylation and ATPase Activity Regulate Anion Flux though the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR).

Authors:  Matthias Zwick; Cinzia Esposito; Manuel Hellstern; Anna Seelig
Journal:  J Biol Chem       Date:  2016-05-12       Impact factor: 5.157

8.  Purification of the cystic fibrosis transmembrane conductance regulator protein expressed in Saccharomyces cerevisiae.

Authors:  Naomi Pollock; Natasha Cant; Tracy Rimington; Robert C Ford
Journal:  J Vis Exp       Date:  2014-05-10       Impact factor: 1.355

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.